Literature DB >> 5364266

Effect of spironolactone and norbolethone on the toxicity of digitalis compounds in the rat.

H Selye, I Mécs, T Tamura.   

Abstract

1. In the rat, both spironolactone (an antimineralocorticoid) and norbolethone (an anabolic steroid) inhibit the characteristic neuromuscular disturbances and the mortality produced by digitoxin, gitalin, proscillaridin, digoxin and digitalin. The corresponding effects of strophanthin K, ouabain and digitoxigenin could not be prevented.2. It may be concluded that, in our experimental conditions, both spironolactone and norbolethone counteract the toxicity of some, but not all, digitalis compounds tested and that both the protective steroids affect the toxicity of the same digitalis derivatives.3. This antidigitalis effect is not merely a secondary consequence of either antimineralocorticoid or anabolic potency because spironolactone lacks anabolic and norbolethone lacks antimineralocorticoid properties. Indeed, it appears that the ability to antagonize the toxicity of digitalis compounds represents a pharmacological property independent of all known steroid hormone actions, since spironolactone is virtually devoid of these.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5364266      PMCID: PMC1703660          DOI: 10.1111/j.1476-5381.1969.tb10585.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  10 in total

1.  Influence of spironolactone pretreatment on pharmacokinetics and metabolism of digitoxin in rats.

Authors:  H F VOHRINGER; L Weller; N Rietbrock
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

Review 2.  Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets.

Authors:  Alexei Y Bagrov; Joseph I Shapiro; Olga V Fedorova
Journal:  Pharmacol Rev       Date:  2009-03       Impact factor: 25.468

3.  Canrenoate disposition in dogs. Tissue distribution and elimination.

Authors:  J Kuhlmann; V Kötter; N Rietbrock
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-06       Impact factor: 3.000

4.  Effects of pretreatment with spironolactone of pharmacokinetics of 4'''-methyldigoxin in man.

Authors:  U Abshagen; H Rennekamp; J Kuhlmann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976       Impact factor: 3.000

Review 5.  Protection by catatoxic steroids against cyclophosphamide-induced organ lesions.

Authors:  H Selye
Journal:  Virchows Arch A Pathol Pathol Anat       Date:  1970

6.  Extrarenal actions of aldosterone antagonists in guinea pigs. II. Reduction of the toxicity of beta-methyl-digoxin.

Authors:  W Schaumann; K Koch; H R Mattern
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

7.  [The effect of probenecid on the distribution of digitoxin, digoxin and ouabain in the mouse].

Authors:  K H Damm; W Braun; H Heckert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

8.  Effects of pretreatment with spironolactone on pharmacokinetics of 4'''-methyldigoxin in rats.

Authors:  U Abshagen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

9.  [Changes in the velocity of drug catabolism and their importance in drug therapy].

Authors:  G F Kahl
Journal:  Klin Wochenschr       Date:  1971-04-01

10.  [Influence of spirolactone on the myocardial potassium balance following strophanthin in man (author's transl)].

Authors:  J Slany; H Mösslacher
Journal:  Klin Wochenschr       Date:  1976-07-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.